Showing results (1-10 of 222) with videos related to
Sort By:
Pageof 23
Frontiers in Neurology|December 28, 2020
Ectopic Lymphoid Follicles in Multiple Sclerosis: Centers for Disease Control?Austin Negron, Olaf Stüve, Thomas G ForsthuberCellular Immunology|May 28, 2019
The role of B cells in multiple sclerosis: Current and future therapiesAustin Negron, Rachel R Robinson, Olaf Stüve, et al.Therapeutic Advances in Neurological Disorders|March 30, 2018
B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targetsThomas G Forsthuber, Daniel M Cimbora, John Nolan Ratchford, et al.Journal of the Neurological Sciences|January 29, 2010
Knowns and unknowns in the future of multiple sclerosis treatmentOlaf StüveJournal of the Neurological Sciences|May 14, 2008
The effects of natalizumab on the innate and adaptive immune system in the central nervous systemOlaf StüveCold Spring Harbor Perspectives in Medicine|March 4, 2018
Natalizumab: Perspectives from the Bench to BedsideAfsaneh Shirani, Olaf StüveTherapeutic Advances in Neurological Disorders|October 25, 2014
Isoniazid in autoimmunity: a trigger for multiple sclerosis?Bardia Nourbakhsh, Olaf StüveJournal of Immunology (Baltimore, Md. : 1950)|February 8, 2017
Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational NeuroimmunologyAfsaneh Shirani, Olaf StüveJournal of Neuroimmunology|April 27, 2020
Limitations of cell-lineage-specific non-dynamic gene recombination in CD11c.Cre+ITGA4fl/fl miceNavid Manouchehri, Rehana Z Hussain, Petra D Cravens, et al.Pageof 23